Dell Technologies (NYSE: DELL) rose 5% after fourth quarter EPS topped consensus, despite conservative guidance for the first ...

Boeing and France’s Safran (EPA: SAF) have reached out to suppliers to inquire about the possible impact of the fire, ...

Looking ahead, Duolingo provided upbeat guidance for Q1 and full-year 2025. The company expects Q1 revenue between ...

Investing.com -- Citi analysts said it is taking partial profits on Ukraine’s 2034A bonds trade, as optimism surrounding a ...

Investing.com -- During a cabinet meeting on Wednesday, U.S. President Donald Trump and Commerce Secretary Howard Lutnick ...

Investing.com -- Amazon (NASDAQ: AMZN) CEO Andy Jassy, in a recent interview with CNBC’s Jon Fortt, discussed the growing ...

ST. PAUL, Minn. - Solventum Corporation (NYSE: SOLV) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 2% in after-hours trading. The healthcare technology ...

ERIE, Pennsylvania - Erie Indemnity Company (NASDAQ: ERIE) reported fourth-quarter earnings that slightly exceeded analyst expectations, sending its stock up 2.6% in after-hours t ...

MALVERN, Pa. - CubeSmart (NYSE: CUBE) reported fourth-quarter earnings that fell short of analyst expectations, sending shares down 4.3% in after-hours trading as the self-storage operator also ...

The behavioral health services provider posted adjusted earnings per share of $0.64 for Q4, missing the consensus estimate of $0.72. Revenue came in at $774.2 million, up 4.2% YoY but below analysts’ ...

Compared to the same quarter last year, Amphastar’s revenue increased 4.7% from $178.1 million. The company’s top-selling product in Q4 was BAQSIMI, which generated sales of $41.8 million.

Total (EPA: TTEF) product revenue for Q4 included $48.7 million from sales of Amtagvi, the company’s recently launched cell therapy for advanced melanoma, and $25.0 million from Proleukin sales. For ...